Support
Exercise of Options | 06-Apr-2023 | 07:00 | RNS |
Removal of Reg S restrictions from shares | 31-Mar-2023 | 17:14 | RNS |
Dividend Record Date | 21-Mar-2023 | 11:44 | RNS |
Audited results for year ended 31 December 2022 | 20-Mar-2023 | 07:00 | RNS |
Exercise of Options | 16-Mar-2023 | 16:35 | RNS |
Removal of Reg S restrictions from common stock | 06-Mar-2023 | 10:39 | RNS |
Director/PDMR Shareholding | 11-Oct-2022 | 18:12 | RNS |
Contract Amendment to a Central Bank | 03-Oct-2022 | 07:00 | RNS |
Exercise of Options | 21-Sep-2022 | 07:00 | RNS |
Appointment of Non-Executive Director | 12-Sep-2022 | 07:05 | RNS |
Interim Results for Six Months Ended 30 June 2022 | 12-Sep-2022 | 07:00 | RNS |
First Banknote Disinfection System Sold | 16-Aug-2022 | 07:00 | RNS |
New Central Bank Contract Amendment | 15-Aug-2022 | 07:00 | RNS |
Share Buy-Back | 28-Jul-2022 | 07:00 | RNS |
Share Buy-Back | 01-Jul-2022 | 14:31 | RNS |
Currency | UK Pounds |
Share Price | 260.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 275.00 |
52 Week Low | 165.00 |
Volume | 0 |
Shares Issued | 0.85m |
Market Cap | £2.21m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
0 @ 0.000p |
CEO | Nabil Lawandy |
You are here: research